Strata Critical Medical, Inc.
SRTA
$6.03
$0.091.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 336.19% | 290.94% | 263.09% | 181.59% | 65.40% |
| Total Depreciation and Amortization | 258.27% | 159.88% | 93.68% | 26.03% | -33.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -789.48% | -561.14% | -607.82% | -374.03% | -58.39% |
| Change in Net Operating Assets | -41.64% | -249.34% | -69.88% | 154.96% | -175.94% |
| Cash from Operations | -2,886.70% | -450.25% | -1,841.80% | -319.94% | 108.97% |
| Capital Expenditure | -31.72% | 47.93% | 55.49% | 27.52% | 46.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 89.45% | 405.60% | 348.06% | 445.66% | 180.79% |
| Cash from Investing | -96.26% | 1,532.45% | 6,965.16% | 1,227.94% | 761.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 47.46% | 46.83% | 22.93% | 52.50% | -8.53% |
| Repurchase of Common Stock | 10.02% | 43.08% | -75.60% | -765.61% | -614.56% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.90% | 45.07% | -54.75% | -478.83% | -744.29% |
| Foreign Exchange rate Adjustments | -466.67% | -4,750.00% | -138.73% | -2,388.89% | 241.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -236.88% | 1,082.25% | 223.59% | 109.54% | 389.76% |